CCL2 and neoplasm: On the contrary, several sets of chemokines and their receptors, such as CCR2/CCL2, CXCR2/CXCL5, and VEGF, have been reported to promote tumor progression in other tumors by enhancing immunosuppressive M2-TAM and MDSC function [65].